Last reviewed · How we verify

NCT05604924

Virtual Reality Training Simulator for Cesarean Section

Completed NA Last updated 13 April 2023
What this trial tests

NA trial testing virtual reality training for cesarean section in Virtual Reality in 150 participants. Completed in 30 November 2022.

Timeline
10 September 2022
Primary endpoint
15 November 2022
30 November 2022

Quick facts

Lead sponsorSeoul National University Bundang Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment150
Start date10 September 2022
Primary completion15 November 2022
Estimated completion30 November 2022
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Bundang Hospital

Who can join

Eligibility, any sex, with Virtual Reality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this is to determine the effectiveness of virtual reality training simulator for cesarean section. Evaluate the effect of using VR surgery on the self-confidence and knowledge of cesarean section procedures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Immersive virtual reality simulation training for cesarean section: a randomized controlled trial.
    Kim HJ, Lee HK, Jang JY, Lee KN, et al · · 2024 · cited 9× · PMID 37939117 · DOI 10.1097/js9.0000000000000843

Verify or expand the search:

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

Other Seoul National University Bundang Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604924.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing